In a 40-week study, the Mounjaro 5-mg, 10-mg, and 15-mg doses were compared to Ozempic 1 mg in 1879 adults with type 2 diabetes who were also taking metformin and had a starting A1C of 8.3%.

Accordion title open

Image Description

Accordion title close

Image Description

In a 40-week study, the Mounjaro 5-mg, 10-mg, and 15-mg doses were compared to Ozempic 1 mg in 1879 adults with type 2 diabetes who were also taking metformin and had a starting A1C of 8.3%.

For people taking Mounjaro, their A1C was lowered on average by 2.0% on the 5-mg dose, 2.2% on the 10-mg dose, and 2.3% on the 15-mg dose. For people taking the Ozempic 1-mg dose, their A1C was lowered on average by 1.9%.